MedPath

Feeding the Patient at Nutritional Risk: Does the Clinical Outcome Improve?

Phase 4
Completed
Conditions
Malnutrition
Interventions
Other: Nutritional therapy
Registration Number
NCT00440453
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Brief Summary

The aim of the present study is to take stronger action in solving the problems of malnutrition in the hospital setting and in the first two months after patient's discharge. The main objective is to evaluate the clinical benefit (eg. QoL, body composition and body function) of nutritional intervention (nutritional therapy) in a sample of patients at nutritional risk according to the NRS 2002.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • all patients coming on station
Exclusion Criteria
  • patients with a screening total score <3 according to the NRS-2002 system
  • less than 18 years of age, expected hospital stay less than 4 days
  • expected survival less than 1 month
  • pregnant or lactating women
  • patients with psychiatric disorders
  • patients with cardiac failure as defined by the Goldmann classification class >II (recent rest pain, unstable angina pectoris)
  • patients with respiratory failure (Peak Flow Rate: PEFR <50%)
  • patients with hepatic dysfunction (Child >A)
  • patients suffering from an intestinal obstruction or ileus
  • patients with renal failure (creatinine >250 μmol/l) or receiving haemodialysis
  • patients that are already receiving, or are planned to receive parenteral nutrition
  • patients unable to understand the German language

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
2Nutritional therapyNutritional treatment
Primary Outcome Measures
NameTimeMethod
Length of stayafter stay
Secondary Outcome Measures
NameTimeMethod
Quality of life2 months after stay
Changes in body weight (measured day 1-2, 8, 28 and 56) and body composition (BMI, MAC, TSF) (measured day 1-2 and 8)during stay
Changes in muscle function (handgrip dynamometry) (measured day 1-2 and 8)during stay
Rate of accurately defined complications (infectious and non-infectious) (Table 2). Infectious are defined according to the US Centre of Disease Control [115].during stay
Rate of accurately defined post-discharge complications (infectious and non-infectious) (Table 2)after stay
Rate of re-hospitalization (within 8 weeks after randomisation)after stay
Rate of mortalityduring and after stay

Trial Locations

Locations (1)

University hospital

🇨🇭

Bern, BE, Switzerland

© Copyright 2025. All Rights Reserved by MedPath